when is tirzepatide off patent Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute when is tirzepatide off patent

The FDA-approved formulation (Wegovy) was studied in trials lasting up to 68 weeks, but ongoing clinical experience and observational studies through 2026 indicate that many patients continue treatment beyond these timeframes with sustained benefit

no human cases confirmed) Long-term Safety: SELECT trial demonstrated 5+ year cardiovascular safety Key Difference: AOD-9604 may have a cleaner tolerability profile (no GI effects), but efficacy failure makes this advantage clinically irrelevant

Or supporting vitamins and minerals that may have increased its metabolism

The greatest health risks come from potential complications if lipedema progresses to later stages and especially if it develops into lipo-lymphedema, which can increase your risk of infections

[DOI] [PubMed] [Google Scholar] 6.Solhjoo M, Goyal A, Saliba F, et al

Patients must reside in Illinois